AIFM2 and metastatic neoplasm: ACSL1 and FSP1 expression was significantly higher in metastatic tumors in the omentum than in tumors of the normal ovary and in primary ovarian cancer, while the expression of 4-HNE and PTGS2 was lower in the omentum metastasis tumor (Fig. 4F).